Genematrix Competitors and Similar CompaniesClear all

Genematrix's competitors and similar companies include Genfit, Teknova and 3B Pharmaceuticals.

	Genematrix Genematrix is a company that develops molecular diagnostic products.	Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.	Teknova Alpha Teknova is a biotech company developing custom products and reagents for bioprocessing, bioproduction, and molecular diagnostics.	3B Pharmaceuticals 3B Pharmaceuticals (3BP) is a biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications.
Founding Date	Founding Date 2000	Founding Date 1999	Founding Date 1996	Founding Date 2008
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development genetics medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare biotech drug development genetics life sciences medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma
Locations	Locations Seongnam-si, KR HQ	Locations Loos, FR HQ Cambridge, US	Locations Hollister, US HQ	Locations Berlin, DE HQ
Employees	Employees N/A	Employees 180	Employees 21026% decrease	Employees 5510% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 280.8 m	Valuation ($) 376.3 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) ₩10.6b (FY, 2025)	Revenue (est.) €65.4m (FY, 2025)	Revenue (est.) $40.5m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ₩4b (FY, 2025)	Cost of goods €302k (FY, 2025)	Cost of goods $27.1m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ₩6.7b (FY, 2025)	Gross profit €70.8m (FY, 2025)	Gross profit $13.4m (FY, 2025)	Gross profit N/A
Net income	Net income (₩1.8b) (FY, 2025)	Net income (€86m) (FY, 2025)	Net income ($17.3m) (FY, 2025)	Net income N/A